Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Stroke With Transfusions Changing to Hydroxyurea (SWiTCH)
This study is ongoing, but not recruiting participants.
Study NCT00122980 Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: July 20, 2005 Last Updated: March 27, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hemochromatosis
Cerebrovascular Accident
Anemia, Sickle Cell
Hematologic Diseases
Additional conditions recognized in this trial
Cerebral Infarction
Stroke
More general conditions related to this trial
Anemia
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Brain Diseases
Brain Infarction
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Genetic Diseases, Inborn
Hemoglobinopathies
Iron Metabolism Disorders
Iron Overload
Metabolic Diseases
Metabolism, Inborn Errors
Metal Metabolism, Inborn Errors
Nervous System Diseases
Vascular Diseases
Interventions listed in this trial
Red Cell Transfusions
Iron Chelation
Hydroxyurea
Phlebotomy
More general drug interventions related to this trial
Antineoplastic Agents
Antisickling Agents
Enzyme Inhibitors
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)
Back to top of Main Content
